bromocriptine has been researched along with Metabolic Syndrome in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auriemma, RS; Colao, A; Graziadio, C; Pirchio, R; Pivonello, R | 1 |
| Bondareva, VM; Derkach, KV; Shpakov, AO | 1 |
| Cincotta, AH | 1 |
| Cincotta, AH; Ezrokhi, M; Luo, S; Zhang, Y | 1 |
| Boaventura, G; Casimiro-Lopes, G; Lisboa, PC; Moura, EG; Oliveira, E; Pazos-Moura, CC | 1 |
| Banerjee, SK; Katare, PB | 1 |
| Barbosa, FR; Domingues, RC; dos Santos Silva, CM; Fontes, R; Gadelha, MR; Lima, GA; Warszawski, L | 1 |
| Frölich, M; Kok, P; Meinders, AE; Pijl, H; Roelfsema, F; Stokkel, MP; van Pelt, J | 1 |
3 review(s) available for bromocriptine and Metabolic Syndrome
| Article | Year |
|---|---|
Metabolic effects of prolactin.
Topics: Bromocriptine; Cabergoline; Dopamine; Dopamine Agonists; Glucose; Humans; Hyperprolactinemia; Lipids; Male; Metabolic Syndrome; Obesity; Prolactin; Receptors, Dopamine; Receptors, Prolactin; Testosterone; Weight Gain | 2022 |
Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.
Topics: Animals; Brain; Bromocriptine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dopamine; Dopamine Agonists; Insulin; Insulin Resistance; Insulin, Regular, Human; Metabolic Syndrome | 2023 |
Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario.
Topics: Allopurinol; Aspirin; Bromocriptine; Cardiovascular Diseases; Clonidine; Colesevelam Hydrochloride; Diabetes Mellitus; Drug Discovery; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Metabolic Syndrome; Piperazines; Tadalafil | 2016 |
1 trial(s) available for bromocriptine and Metabolic Syndrome
| Article | Year |
|---|---|
Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women.
Topics: Adult; Blood Glucose; Bromocriptine; Calorimetry, Indirect; Circadian Rhythm; Cross-Over Studies; Dopamine Agonists; Eating; Energy Metabolism; Fatty Acids, Nonesterified; Female; Humans; Insulin; Insulin Resistance; Metabolic Syndrome; Middle Aged; Nitrogen; Obesity; Oxygen Consumption; Prolactin; Receptors, Dopamine D2; Urea | 2006 |
4 other study(ies) available for bromocriptine and Metabolic Syndrome
| Article | Year |
|---|---|
[Restriction of breastfeeding in the early postnatal period leads to metabolic and endocrine disorders in eighteen-month-old male rats.]
Topics: Animals; Bromocriptine; Female; Insulin Resistance; Lactation; Male; Metabolic Syndrome; Rats; Thyroid Hormones | 2022 |
Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet.
Topics: Animals; Bromocriptine; Cardiovascular Diseases; Circadian Rhythm; Diet, High-Fat; Hormone Antagonists; Hypertension; Insulin Resistance; Male; Metabolic Syndrome; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley | 2021 |
Effects of running wheel training on adult obese rats programmed by maternal prolactin inhibition.
Topics: Animals; Bromocriptine; Female; Glycogen; L-Lactate Dehydrogenase; Lactation; Lipid Metabolism; Male; Metabolic Syndrome; Mothers; Motor Activity; Muscles; Obesity; Physical Conditioning, Animal; Prolactin; Rats; Rats, Wistar; Weaning | 2013 |
BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists.
Topics: Adult; Aftercare; Aged; Blood Glucose; Body Composition; Body Mass Index; Body Weight; Bromocriptine; Cabergoline; Cholesterol, HDL; Cholesterol, LDL; Dopamine Agonists; Ergolines; Female; Humans; Insulin; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Metabolome; Middle Aged; Obesity; Prevalence; Prolactinoma; Waist Circumference; Weight Gain; Young Adult | 2011 |